Company profile
The CannaBusiness Group, Inc.
OTC: CBGI · Healthcare · Drug Manufacturers - Specialty & Generic
#879 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 49
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ Piotroski F, growth stability
Methodology →Revenue TTM
$16.3M
Rev growth YoY (TTM)
+13.8%
Net income (FY)
-$816.1k
Employees
71
as of 2026-07-12
Market cap
$1.8k
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$950.3k$950.3k2013
Net income-$816.1k-$816.1k2013
Operating income-$816.1k-$816.1k2013
Total assets$2.3M$2.3M2013
Liabilities$3.1M$3.1M2013
Equity-$741.2k-$741.2k2013
Revenue trend
FY2002 – FY2013 · USD
FY02
FY03
FY04
FY05
FY06
FY07
FY12
FY13
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is The CannaBusiness Group, Inc.’s revenue?
The CannaBusiness Group, Inc. booked $950.3k in FY2013 revenue, growing 636% year over year — faster than 95% of Healthcare companies we track, at a -85.9% net margin.
Peers · Healthcare
60 Degrees Pharmaceuticals, Inc.34DShattuck Labs, Inc.49DRavenQuest BioMed Inc.——INDVR Brands Inc.——Quick-Med Technologies, Inc.——ProKidney Corp.41DNeighbors
Orange →Key facts
CEOJeff Jiron
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersMission Viejo, CA
ExchangeOTC: CBGI
Employees71
IPO date2000-08-25
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.